Ivc Wealth Advisors LLC Crispr Therapeutics Ag Transaction History
Ivc Wealth Advisors LLC
- $221 Million
- Q3 2025
A detailed history of Ivc Wealth Advisors LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Ivc Wealth Advisors LLC holds 4,994 shares of CRSP stock, worth $361,166. This represents 0.15% of its overall portfolio holdings.
Number of Shares
4,994
Previous 4,616
8.19%
Holding current value
$361,166
Previous $224,000
44.2%
% of portfolio
0.15%
Previous 0.11%
Shares
2 transactions
Others Institutions Holding CRSP
# of Institutions
541Shares Held
68.7MCall Options Held
3.67MPut Options Held
2.25M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$736 Million4.09% of portfolio
-
Capital International Investors Los Angeles, CA5.59MShares$405 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.68MShares$266 Million0.11% of portfolio
-
State Street Corp Boston, MA3.27MShares$237 Million0.01% of portfolio
-
Ubs Group Ag2.84MShares$206 Million0.02% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $5.64B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....